Analysts Issue Forecasts for Astera Labs Q1 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Stock analysts at Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for Astera Labs in a research report issued on Tuesday, February 11th. Northland Capmk analyst G. Richard anticipates that the company will post earnings per share of $0.09 for the quarter. Northland Capmk has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.22 EPS.

A number of other equities research analysts also recently commented on the company. Citigroup began coverage on Astera Labs in a report on Monday, November 18th. They issued a “buy” rating and a $120.00 target price for the company. Needham & Company LLC restated a “buy” rating and issued a $140.00 price target on shares of Astera Labs in a research report on Tuesday. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a research report on Tuesday, January 28th. JPMorgan Chase & Co. raised their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Finally, Morgan Stanley dropped their price target on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $115.33.

Astera Labs Price Performance

Astera Labs stock opened at $88.19 on Thursday. Astera Labs has a one year low of $36.22 and a one year high of $147.39. The business has a fifty day moving average of $121.35 and a two-hundred day moving average of $82.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Whittier Trust Co. of Nevada Inc. purchased a new stake in Astera Labs in the 4th quarter valued at about $25,000. Steward Partners Investment Advisory LLC grew its holdings in Astera Labs by 99.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after buying an additional 99 shares during the period. Kestra Investment Management LLC purchased a new stake in Astera Labs in the 4th quarter valued at about $28,000. Geneos Wealth Management Inc. purchased a new stake in Astera Labs in the 4th quarter valued at about $36,000. Finally, Global Retirement Partners LLC grew its holdings in Astera Labs by 3,155.6% in the 4th quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after buying an additional 284 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, Director Stefan A. Dyckerhoff sold 197,297 shares of Astera Labs stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the completion of the sale, the director now owns 6,148 shares in the company, valued at approximately $556,455.48. This trade represents a 96.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Michael Truett Tate sold 16,000 shares of Astera Labs stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the completion of the sale, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This trade represents a 1.12 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 846,452 shares of company stock worth $86,427,256.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.